Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122002) titled 'Exploratory clinical study on the diagnostic efficacy of neurohypotensin receptor 1 (NTSR1)-targeted PET imaging for malignant solid tumors' on April 8.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Affiliated Hospital of Jinan University
Condition:
Tumor
Intervention:
Gold Standard:Immunohistochemical Pathology Results
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-20
Target Sample Size: Target condition:16;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...